A detailed history of Barclays PLC transactions in Adagene Inc. stock. As of the latest transaction made, Barclays PLC holds 186,903 shares of ADAG stock, worth $351,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186,903
Previous 186,903 -0.0%
Holding current value
$351,377
Previous $415,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.12 - $3.24 $24,958 - $38,144
11,773 Added 6.72%
186,903 $572,000
Q1 2024

May 15, 2024

BUY
$1.96 - $4.15 $343,254 - $726,789
175,130 New
175,130 $490,000

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $81.6M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.